Prescribing Buprenorphine: Adapting to New Realities

Sponsor: Central East Addiction Technology Transfer Center Network

The opioid epidemic continues to be a major public health crisis, driven largely by fentanyl and other synthetic opioids. Buprenorphine is a partial opioid agonist that binds to opioid receptors in the brain. Its unique pharmacological profile, characterized by a ceiling effect, limits the risk of overdose and makes it a safer alternative to full agonists like methadone. Newer formulations and updated initiation strategies can help stabilize patients and support long-term recovery. The session can be helpful to all clinicians who care for individuals with opioid use. Clinicians can educate and reassure their patients on these updates and guide them to treatment.

For more information and to register click here

Event Details